Switch to:
Repros Therapeutics Inc (NAS:RPRX)
EV/EBITDA
-4.60 (As of Today)

EV/EBITDA ratio is calculated as enterprise value divided by its EBITDA. As of today, Repros Therapeutics Inc's enterprise value is $148.32 Mil. Repros Therapeutics Inc's earnings before depreciation and amortization for the trailing twelve months (TTM) ended in Mar. 2015 was $-32.24 Mil. Therefore, Repros Therapeutics Inc's EV/EBITDA ratio for today is -4.60.

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

As of today, Repros Therapeutics Inc's stock price is $7.66. Repros Therapeutics Inc's earnings per share for the trailing twelve months (TTM) ended in Mar. 2015 was $-1.38. Therefore, Repros Therapeutics Inc's P/E Ratio for today is .

The "classic" EV/EBITDA ratio is much better in capturing debt and net cash than the P/E Ratio.


Definition

Repros Therapeutics Inc's EV/EBITDA for today is calculated as:

EV/EBITDA=Enterprise Value (Today)/Earnings Before Depreciation and Amortization (TTM)
=148.318/-32.243
=-4.60

Repros Therapeutics Inc's current Enterprise Value is $148.32 Mil.
Repros Therapeutics Inc's Earnings Before Depreciation and Amortization for the trailing twelve months (TTM) ended in Mar. 2015 was -8.535 (Jun. 2014 ) + -7.292 (Sep. 2014 ) + -7.901 (Dec. 2014 ) + -8.515 (Mar. 2015 ) = $-32.24 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Explanation

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

Repros Therapeutics Inc's P/E Ratio for today is calculated as:

P/E Ratio=Share Price (Today)/Earnings Per Share (TTM)
=7.66/-1.376
=

Repros Therapeutics Inc's share price for today is $7.66.
Repros Therapeutics Inc's Earnings Per Share for the trailing twelve months (TTM) ended in Mar. 2015 was -0.38 (Jun. 2014 ) + -0.32 (Sep. 2014 ) + -0.326 (Dec. 2014 ) + -0.35 (Mar. 2015 ) = $-1.38.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Study has found that the companies with the lowest EV/EBITDA outperforms companies measured as cheap by other ratios such as P/E Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Related Terms

Enterprise Value, Earnings Before Depreciation and Amortization, P/E Ratio


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Repros Therapeutics Inc Annual Data

Dec05Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13Dec14
ev2ebitda -4.27-8.65-6.45-5.63-0.68-5.17-4.44-13.65-12.21-6.01

Repros Therapeutics Inc Quarterly Data

Dec12Mar13Jun13Sep13Dec13Mar14Jun14Sep14Dec14Mar15
ev2ebitda -13.65-12.34-12.46-18.83-12.21-11.49-10.89-5.68-6.01-5.29
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK